Celsion (CLSN) Reports Q2 Loss of $0.46

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Celsion (CLSN) Reports Q2 Loss of $0.46

Celsion Corporation Reports Second Quarter 2018 Financial Results and Provides Business Update

August 14, 2018 8:30 AM EDT

  Strong Balance Sheet With Cash Sufficient to Fund Operations Into the First Half of 2020

Quarterly and Year-to-Date Cash Expenses Consistent With Prior Guidance             Company to Hold Conference Call on Tuesday, August 14, 2018 at 11:00 a.m. EDT

LAWRENCEVILLE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the... More